SABRINA CHANG: Open Payments
NPI 1497378970 · VALLEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Aurinia Pharma U.S., Inc. | 8 | $207 |
| Alnylam Pharmaceuticals Inc. | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 2 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Calliditas Therapeutics US Inc. | 2 | $46 |
| Fresenius Kabi USA, LLC | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $27 |
| SOBI, INC | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: LUPKYNIS, SAPHNELO, GIVLAARI, ILARIS, OXLUMO, TARPEYO, IDACIO, JYNARQUE.
Industry payments across CA — which companies pay providers there.
